JP2019514855A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514855A5 JP2019514855A5 JP2018551137A JP2018551137A JP2019514855A5 JP 2019514855 A5 JP2019514855 A5 JP 2019514855A5 JP 2018551137 A JP2018551137 A JP 2018551137A JP 2018551137 A JP2018551137 A JP 2018551137A JP 2019514855 A5 JP2019514855 A5 JP 2019514855A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- weight
- pharmaceutically active
- binding polypeptide
- active binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023017273A JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16163178 | 2016-03-31 | ||
| EP16163178.3 | 2016-03-31 | ||
| PCT/EP2017/057775 WO2017167997A1 (en) | 2016-03-31 | 2017-03-31 | Compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023017273A Division JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514855A JP2019514855A (ja) | 2019-06-06 |
| JP2019514855A5 true JP2019514855A5 (enExample) | 2020-05-14 |
| JP7224917B2 JP7224917B2 (ja) | 2023-02-20 |
Family
ID=55646428
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018551137A Active JP7224917B2 (ja) | 2016-03-31 | 2017-03-31 | 組成物 |
| JP2023017273A Active JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023017273A Active JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10772839B2 (enExample) |
| EP (1) | EP3435982A1 (enExample) |
| JP (2) | JP7224917B2 (enExample) |
| KR (1) | KR102376369B1 (enExample) |
| CN (2) | CN117243904A (enExample) |
| AU (2) | AU2017240190A1 (enExample) |
| CA (2) | CA3019482A1 (enExample) |
| IL (1) | IL261792B (enExample) |
| SG (1) | SG11201807402PA (enExample) |
| WO (2) | WO2017167997A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103254309B (zh) * | 2005-05-18 | 2017-09-26 | 埃博灵克斯股份有限公司 | 针对肿瘤坏死因子α的改进的纳米体TM |
| HK1250040A1 (zh) | 2015-03-31 | 2018-11-23 | Sorriso Pharmaceuticals, Inc. | 多肽 |
| CA2981098A1 (en) | 2015-03-31 | 2016-10-06 | Vhsquared Limited | Peptide construct having a protease-cleavable linker |
| JP6895421B2 (ja) * | 2015-03-31 | 2021-06-30 | ブイエイチスクエアード リミテッド | ポリペプチド |
| EP3435982A1 (en) | 2016-03-31 | 2019-02-06 | VHsquared Limited | Compositions |
| EP3519438A1 (en) * | 2016-09-30 | 2019-08-07 | VHsquared Limited | Compositions |
| TW201834711A (zh) | 2016-12-14 | 2018-10-01 | 美商寶珍那提公司 | 以tnf抑制劑治療胃腸道疾病 |
| US20210138213A1 (en) * | 2017-03-30 | 2021-05-13 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| EP3459527B1 (en) * | 2017-09-20 | 2022-11-23 | Tillotts Pharma Ag | Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization |
| WO2019246313A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a tnf inhibitor |
| US11291654B2 (en) * | 2018-09-13 | 2022-04-05 | Syneurx International (Taiwan) Corp. | Formulations of cycloserine compounds and applications thereof |
| CN116726362A (zh) | 2018-11-19 | 2023-09-12 | 比奥拉治疗股份有限公司 | 用生物治疗剂治疗疾病的方法和装置 |
| EP3908602A1 (en) | 2019-01-07 | 2021-11-17 | Bactolife ApS | Pathogen binding proteins |
| WO2020243393A1 (en) * | 2019-05-30 | 2020-12-03 | Vta Labs, Llc | Design of a single oral delivery system containing a monoclonal antibody for the simultaneous treatment of chron's disease and ulcerative colitis |
| EP3986931A1 (en) | 2019-06-21 | 2022-04-27 | Sorriso Pharmaceuticals, Inc. | Polypeptides |
| AU2020294980A1 (en) | 2019-06-21 | 2022-02-17 | Sorriso Pharmaceuticals, Inc. | Polypeptides |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| JP2023529068A (ja) * | 2020-05-18 | 2023-07-07 | 深▲チェン▼市塔吉瑞生物医薬有限公司 | 固体形態の大環状化合物、その調製およびその使用 |
| CN113768051B (zh) * | 2020-06-09 | 2024-03-19 | 中粮营养健康研究院有限公司 | 饲料添加剂及其制备方法和其在饲料中的应用以及替抗饲料 |
| GB202017863D0 (en) * | 2020-11-12 | 2020-12-30 | Intract Pharma Ltd | Novel compositions |
| WO2024163874A2 (en) * | 2023-02-03 | 2024-08-08 | Avexegen Therapeutics, Inc. | Stable and controlled release formulations of neuregulin-4 analogs |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2010126A (en) | 1934-03-19 | 1935-08-06 | Frank L Mclaughlin | Measuring and dispensing can |
| CA2110899C (en) | 1991-06-21 | 2006-08-08 | Jacob G. Michael | Orally administrable therapeutic proteins and method of making |
| EP0725789B1 (en) * | 1993-09-20 | 2003-03-19 | Anadis Ltd. | Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| EP1558647B1 (en) | 2002-11-08 | 2015-06-10 | Ablynx N.V. | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| US8007827B2 (en) * | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| AP2007004019A0 (en) * | 2004-11-25 | 2007-06-30 | Unilever Plc | Heavy chain and single domain antibodies |
| EP1909831A4 (en) | 2005-06-14 | 2013-02-20 | Amgen Inc | SELF-BUFFING PROTEIN FORMULATIONS |
| US20080026820A1 (en) * | 2006-07-05 | 2008-01-31 | Aruze Gaming America, Inc. | Slot machine and playing method thereof |
| KR20090086060A (ko) | 2006-09-12 | 2009-08-10 | 코스모 테크놀러지스 리미티드 | 단백질의 경구 또는 직장 투여를 위한 약학적 조성물 |
| KR20090060453A (ko) | 2006-09-25 | 2009-06-12 | 메디뮨 엘엘씨 | 안정화된 항체 제제 및 그것의 용도 |
| US20080145420A1 (en) | 2006-12-13 | 2008-06-19 | Simon Michael R | HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
| EP2079445B1 (en) * | 2007-02-20 | 2015-11-04 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
| EP2380564B1 (en) * | 2007-04-04 | 2014-10-22 | Sigmoid Pharma Limited | An oral pharmaceutical composition |
| US20080260820A1 (en) | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| GB0724331D0 (en) | 2007-12-13 | 2008-01-23 | Domantis Ltd | Compositions for pulmonary delivery |
| WO2009037264A2 (en) | 2007-09-17 | 2009-03-26 | Da Volterra | Colonic delivery of antimicrobial agents |
| KR101245604B1 (ko) | 2007-11-13 | 2013-03-21 | 메리테이지 파마, 인크. | 코르티코스테로이드 조성물 |
| EP3011953A1 (en) | 2008-10-29 | 2016-04-27 | Ablynx N.V. | Stabilised formulations of single domain antigen binding molecules |
| US9056050B2 (en) * | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| CN101964403A (zh) | 2009-07-23 | 2011-02-02 | 比克国际(天津)有限公司 | 一种电池组的封装方法及电池组 |
| EP2533814A2 (en) | 2010-02-11 | 2012-12-19 | Ablynx N.V. | Delivery of immunoglobulin variable domains and constructs thereof |
| RU2626512C2 (ru) | 2010-03-01 | 2017-07-28 | Цитодин, Инк. | Концентрированные белковые фармацевтические составы и их применение |
| CN103025319B (zh) | 2010-03-10 | 2015-07-01 | 因卡伯实验室有限责任公司 | 用于利用可吞咽式药剂递送装置递送到肠道内腔中的治疗剂制剂 |
| EP2691415B1 (en) | 2011-03-28 | 2018-07-11 | Ablynx N.V. | Method for producing solid formulations comprising immunoglobulin single variable domains |
| JP6024025B2 (ja) | 2011-05-02 | 2016-11-09 | イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． | 少容量投与用のアロタイプ選択抗体の限外濾過濃縮 |
| MY188825A (en) | 2012-05-18 | 2022-01-06 | Genentech Inc | High-concentration monoclonal antibody formulations |
| JP2015527357A (ja) * | 2012-08-21 | 2015-09-17 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 単一可変ドメインとカモスタットメシル酸塩（ｃｍ）とを含んでなる組成物 |
| KR20150132332A (ko) | 2013-03-15 | 2015-11-25 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 저농도 항체 제형 |
| US20160228371A1 (en) | 2013-10-18 | 2016-08-11 | Abbvie Inc. | Stable solid units and methods of making the same |
| EP3142645A4 (en) | 2014-05-15 | 2017-12-27 | Rani Therapeutics, LLC | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| HK1250040A1 (zh) | 2015-03-31 | 2018-11-23 | Sorriso Pharmaceuticals, Inc. | 多肽 |
| JP6895421B2 (ja) * | 2015-03-31 | 2021-06-30 | ブイエイチスクエアード リミテッド | ポリペプチド |
| EP3435982A1 (en) | 2016-03-31 | 2019-02-06 | VHsquared Limited | Compositions |
-
2017
- 2017-03-31 EP EP17716044.7A patent/EP3435982A1/en active Pending
- 2017-03-31 SG SG11201807402PA patent/SG11201807402PA/en unknown
- 2017-03-31 WO PCT/EP2017/057775 patent/WO2017167997A1/en not_active Ceased
- 2017-03-31 AU AU2017240190A patent/AU2017240190A1/en not_active Abandoned
- 2017-03-31 JP JP2018551137A patent/JP7224917B2/ja active Active
- 2017-03-31 CA CA3019482A patent/CA3019482A1/en active Pending
- 2017-04-03 CN CN202311230166.8A patent/CN117243904A/zh active Pending
- 2017-04-03 WO PCT/MT2017/000001 patent/WO2017171535A2/en not_active Ceased
- 2017-04-03 CA CA3053757A patent/CA3053757A1/en not_active Abandoned
- 2017-04-03 CN CN201780020634.5A patent/CN109152738B/zh active Active
- 2017-04-03 KR KR1020187029576A patent/KR102376369B1/ko active Active
-
2018
- 2018-09-16 IL IL261792A patent/IL261792B/en unknown
- 2018-09-25 US US16/140,843 patent/US10772839B2/en active Active
-
2020
- 2020-08-07 US US16/988,506 patent/US10980748B2/en active Active
-
2023
- 2023-01-24 AU AU2023200377A patent/AU2023200377B2/en active Active
- 2023-02-08 JP JP2023017273A patent/JP7496906B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019514855A5 (enExample) | ||
| US11090269B1 (en) | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | |
| US20100330129A1 (en) | Gastroresistant Pharmaceutical Formulations Containing Rifaximin | |
| JP2016164170A (ja) | プロトンポンプ阻害剤を含む制御放出組成物 | |
| WO2006070781A1 (ja) | 塩基性薬物又はその塩を含有するマトリックス型徐放性製剤およびその製造方法 | |
| CN109310642B (zh) | 美沙拉嗪的口服药物组合物 | |
| CN108289848A (zh) | 包含urat1的有效抑制剂的药物组合物 | |
| JPH07223970A (ja) | 消化管内適所放出製剤 | |
| CN103269691A (zh) | 用于控制释放美沙拉嗪的口服药物片剂和其获得方法 | |
| WO2023047274A1 (en) | Extended release pharmaceutical compositions of dydrogesterone | |
| US20070122480A1 (en) | Sustained release formulations | |
| TWI688411B (zh) | 腸溶錠 | |
| CN105338970A (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
| RU2738114C2 (ru) | Пероральные фармацевтические композиции никотинамида | |
| US20110086102A1 (en) | Delayed release compositions | |
| US20090028944A1 (en) | Pharmaceutical compositions comprising mesalamine | |
| CN113382720A (zh) | 用于美沙拉嗪或其衍生物施用的固体口服药物组合物 | |
| EP3796908B1 (en) | Controlled release propiverine formulations | |
| US20230181545A1 (en) | Controlled-release pharmaceutical formulations for treatment of intestinal infections | |
| US20200054659A1 (en) | Extended release capecitabine capsules | |
| KR20090107960A (ko) | 심혈관계 질환 치료용 약제학적 제제 | |
| WO2009047800A2 (en) | Oral controlled release composition of carvedilol | |
| WO2011046546A1 (en) | Delayed release compositions | |
| CA2750611A1 (en) | Chronotherapeutic pharmaceutical composition |